CL.CN
Cresco Labs Inc
Price:  
1.37 
CAD
Volume:  
407,700.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CL.CN Relative Valuation

-285.1%
Upside

As of 2025-09-18, the Relative Valuation of Cresco Labs Inc (CL.CN) is (2.54) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.37 CAD, the upside of Cresco Labs Inc based on Relative Valuation is -285.1%.

The range of the Relative Valuation is (2.51) - (2.56) CAD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 18.8x - 20.5x 19.6x
Forward P/E multiples 20.2x - 22.2x 21.2x
Fair Price (2.51) - (2.56) (2.54)
Upside -283.5% - -286.6% -285.1%
1.37 CAD
Stock Price
(2.54) CAD
Fair Price

CL.CN Relative Valuation - Historical P/E Data

Date P/E
2025-09-16 -11.01
2025-09-15 -10.61
2025-09-12 -11.01
2025-09-11 -11.57
2025-09-10 -12.94
2025-09-09 -13.66
2025-09-08 -13.10
2025-09-05 -13.26
2025-09-04 -12.61
2025-09-03 -12.69
2025-09-02 -15.10
2025-08-29 -16.63
2025-08-28 -16.55
2025-08-27 -15.83
2025-08-26 -15.67
2025-08-25 -14.86
2025-08-22 -13.74
2025-08-21 -13.42
2025-08-20 -12.13
2025-08-19 -11.33
2025-08-18 -12.61
2025-08-15 -10.61
2025-08-14 -11.01
2025-08-13 -12.05
2025-08-12 -11.33
2025-08-11 -10.61
2025-08-08 -8.19
2025-08-07 -7.71
2025-08-06 -7.47
2025-08-05 -7.79
2025-08-01 -6.91
2025-07-31 -6.51
2025-07-30 -7.15
2025-07-29 -6.67
2025-07-28 -7.55
2025-07-25 -7.47
2025-07-24 -6.83
2025-07-23 -6.51
2025-07-22 -6.67
2025-07-21 -6.91
2025-07-18 -6.27
2025-07-17 -6.03
2025-07-16 -5.70
2025-07-15 -5.86
2025-07-14 -6.91
2025-07-11 -7.31
2025-07-10 -7.95
2025-07-09 -6.59
2025-07-08 -5.95
2025-07-07 -5.46